CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,537 enrolled
Drug / intervention
No Treatmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03064841
NCT03064841N/ACompleted

Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China: A Nationwide Cross-sectional Study

Boehringer Ingelheim·observational·Posted Feb 27, 2017·Updated Aug 28, 2019

In Brief

An observational study evaluating No Treatment for Type 2 Diabetes Mellitus. Completed, enrolled 1,537 participants across 18 sites.

Detailed Summary

This is a multi-centre, cross-sectional, non-interventional study assessing blood glucose target attainment, anti-hyperglycaemic treatment pattern and the clinical characteristics in older outpatients with Type 2 Diabetes Mellitus (T2DM) in hospitals of China. This study is designed to collect information of older T2DM patients in a real life setting

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 27, 2017
Enrollment StartMar 9, 2017
Primary CompletionDec 30, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.3 years ago

Interventions

No Treatmentdrug

No treatment